Skip to content
Menu

Gelteq Limited GELS

Full chart Compare
Set alert

Price alert · GELS

All alert types
0.38 USD 0.00 (-0.13%)

At closeNov 13, 2026, 4:00 PM EST

0.38 0.00 -0.08%

After hours · Nov 13, 4:00 PM ET

0.38 Day range 0.4112
0.3803 52-week range 1.53
YTD
-52.46%
1 year
-62.35%
Market cap
4.07M
Revenue (ttm)
131.76K
EPS (ttm)
-0.44
Shares out
9.44M
YTD return
-52.46%
1-year return
-62.35%
Volume
13.31K
Avg volume
2.85M
Open
0.3801
Previous close
0.3808
Day's range
0.38 – 0.4112
52-week range
0.3803 – 1.53

5D -0.0409 (-8.87%)

0.42500.45000.4750WedThuFriMonTue0.4201

Key statistics

Enterprise value
15.48M
PEG ratio
0.00
Price / sales
174.07
Price / book
1.21
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
-68.90%
Free cash flow
-463.50K
Total cash
399.22K
Total debt
2.49M
Return on equity
-18.75%
Short % of float
0.00%
50-day average
2.45
200-day average
2.45

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
GELS Revenue — quarterly 0
2023-Q4 20232024-Q4 2024
GELS Net income — quarterly -1.13M
2023-Q4 20232024-Q4 2024

About Gelteq Limited

Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Australia
Website
gelteq.com

News

Your note

Sign in to keep a note on GELS — it syncs with the Stock Master app.